Eagle Bay Advisors LLC Sells 143 Shares of Danaher Co. (NYSE:DHR)

Eagle Bay Advisors LLC lessened its holdings in Danaher Co. (NYSE:DHR) by 20.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 544 shares of the conglomerate’s stock after selling 143 shares during the period. Eagle Bay Advisors LLC’s holdings in Danaher were worth $125,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. Coronation Fund Managers Ltd. boosted its stake in Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after buying an additional 1,470 shares during the period. Thoroughbred Financial Services LLC lifted its holdings in shares of Danaher by 124.1% in the 2nd quarter. Thoroughbred Financial Services LLC now owns 1,956 shares of the conglomerate’s stock worth $488,000 after acquiring an additional 1,083 shares during the last quarter. Wealthspire Advisors LLC raised its position in Danaher by 3.5% in the 2nd quarter. Wealthspire Advisors LLC now owns 4,823 shares of the conglomerate’s stock worth $1,205,000 after purchasing an additional 165 shares during the period. Quilter Plc raised its position in Danaher by 1.6% in the 2nd quarter. Quilter Plc now owns 59,059 shares of the conglomerate’s stock worth $14,756,000 after purchasing an additional 927 shares during the period. Finally, Fairfield Financial Advisors LTD purchased a new position in shares of Danaher during the second quarter valued at approximately $1,384,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $239.83 on Tuesday. The company has a 50 day moving average of $235.52 and a two-hundred day moving average of $253.65. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70. The company has a market cap of $173.22 billion, a price-to-earnings ratio of 45.77, a price-to-earnings-growth ratio of 4.32 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the previous year, the business earned $2.02 EPS. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is currently 20.61%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on DHR. Stephens reiterated an “overweight” rating and issued a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Raymond James cut their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Guggenheim initiated coverage on shares of Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective for the company. Finally, Royal Bank of Canada dropped their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.